Quarterly Changes to the NASDAQ Q-50 Index
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Isis Pharma (ISIS) Initiates ISIS-ANGPTL3Rx Phase 1
March 19, 2014 7:03 AM EDTIsis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 clinical study for ISIS-ANGPTL3Rx, an antisense drug targeting angiopoietin-like 3 protein (ANGPTL3), an independent risk factor for cardiovascular disease. ISIS-ANGPTL3Rx is designed to act as a broad dyslipidemia agent. By reducing ANGPTL3, ISIS-ANGPTL3Rx has the potential to reduce LDL-cholesterol and triglycerides, and to increase insulin sensitivity. Isis plans to evaluate ISIS-ANGPTL3Rx in patients who have severe metabolic or... More
Sprouts Farmers Market (SFM) Files 15M Common Shelf for Shareholders
March 17, 2014 5:27 PM EDTSprouts Farmers Market, Inc. (Nasdaq: SFM) filed a registration with the U.S. SEC to sell, from time to time, up to 15 million shares of its Common Stock on behalf of Selling Shareholders. The company will not receive proceeds from the secondary sales.... More
